Zirabev - supply shortage
Resolved
bevacizumab
ShortageHuman
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
Shortage information
The shortage affecting Zirabev has been resolved and the information and recommendations which were issued during the shortage no longer apply.
Key facts
- Medicines affected
- Zirabev
- Supply shortage status
- Resolved
- International non-proprietary name (INN) or common name
- bevacizumab
- Therapeutic area (MESH)
- Colorectal Neoplasms
- Breast Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Uterine Cervical Neoplasms
- Pharmaceutical forms affected
- Concentrate for solution for infusion
- Strengths affected
- 100mg/4ml
- 400mg/16ml
Key dates
- First published
- Last updated